These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22848674)

  • 1. Comprehensive mutation analysis in colorectal flat adenomas.
    Voorham QJ; Carvalho B; Spiertz AJ; Claes B; Mongera S; van Grieken NC; Grabsch H; Kliment M; Rembacken B; van de Wiel MA; Quirke P; Mulder CJ; Lambrechts D; van Engeland M; Meijer GA
    PLoS One; 2012; 7(7):e41963. PubMed ID: 22848674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA.
    Chang LC; Chiu HM; Shun CT; Liang JT; Lin JT; Chen CC; Lee YC; Wu MS
    BMC Gastroenterol; 2014 Dec; 14():221. PubMed ID: 25551625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations.
    Mouradov D; Domingo E; Gibbs P; Jorissen RN; Li S; Soo PY; Lipton L; Desai J; Danielsen HE; Oukrif D; Novelli M; Yau C; Holmes CC; Jones IT; McLaughlin S; Molloy P; Hawkins NJ; Ward R; Midgely R; Kerr D; Tomlinson IP; Sieber OM
    Am J Gastroenterol; 2013 Nov; 108(11):1785-93. PubMed ID: 24042191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.
    Yang TW; Gao YH; Ma SY; Wu Q; Li ZF
    World J Gastroenterol; 2017 May; 23(17):3066-3076. PubMed ID: 28533663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct molecular features of different macroscopic subtypes of colorectal neoplasms.
    Konda K; Konishi K; Yamochi T; Ito YM; Nozawa H; Tojo M; Shinmura K; Kogo M; Katagiri A; Kubota Y; Muramoto T; Yano Y; Kobayashi Y; Kihara T; Tagawa T; Makino R; Takimoto M; Imawari M; Yoshida H
    PLoS One; 2014; 9(8):e103822. PubMed ID: 25093594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and molecular correlations in traditional serrated adenoma.
    Sekine S; Yamashita S; Yamada M; Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Ushijima T; Saito Y
    J Gastroenterol; 2020 Apr; 55(4):418-427. PubMed ID: 32052185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
    Escobar D; Bushara O; Sun L; Liao J; Yang GY
    Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 5q loss in colorectal flat adenomas.
    Voorham QJ; Carvalho B; Spiertz AJ; van Grieken NC; Mongera S; Rondagh EJ; van de Wiel MA; Jordanova ES; Ylstra B; Kliment M; Grabsch H; Rembacken BJ; Arai T; de Bruïne AP; Sanduleanu S; Quirke P; Mulder CJ; van Engeland M; Meijer GA
    Clin Cancer Res; 2012 Sep; 18(17):4560-9. PubMed ID: 22761468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation.
    Yachida S; Mudali S; Martin SA; Montgomery EA; Iacobuzio-Donahue CA
    Am J Surg Pathol; 2009 Dec; 33(12):1823-32. PubMed ID: 19745699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC5AC/β-catenin expression and KRAS gene alteration in laterally spreading colorectal tumors.
    Nakae K; Mitomi H; Saito T; Takahashi M; Morimoto T; Hidaka Y; Sakamoto N; Yao T; Watanabe S
    World J Gastroenterol; 2012 Oct; 18(39):5551-9. PubMed ID: 23112547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flat-type colorectal advanced adenomas (laterally spreading tumors) have different genetic and epigenetic alterations from protruded-type advanced adenomas.
    Takahashi T; Nosho K; Yamamoto H; Mikami M; Taniguchi H; Miyamoto N; Adachi Y; Itoh F; Imai K; Shinomura Y
    Mod Pathol; 2007 Jan; 20(1):139-47. PubMed ID: 17143260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans.
    Scholtka B; Schneider M; Melcher R; Katzenberger T; Friedrich D; Berghof-Jäger K; Scheppach W; Steinberg P
    Cancer Epidemiol; 2009 Aug; 33(2):123-9. PubMed ID: 19679059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of K-ras, BRAF, and PIK3CA mutations in laterally-spreading tumors of the colorectum.
    Kaji E; Kato J; Suzuki H; Akita M; Horii J; Saito S; Higashi R; Ishikawa S; Kuriyama M; Hiraoka S; Uraoka T; Yamamoto K
    J Gastroenterol Hepatol; 2011 Mar; 26(3):599-607. PubMed ID: 21332555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation epigenotypes and genetic features in colorectal laterally spreading tumors.
    Sakai E; Ohata K; Chiba H; Matsuhashi N; Doi N; Fukushima J; Endo H; Takahashi H; Tsuji S; Yagi K; Matsusaka K; Aburatani H; Nakajima A; Kaneda A
    Int J Cancer; 2014 Oct; 135(7):1586-95. PubMed ID: 24590867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A correlation of the endoscopic characteristics of colonic laterally spreading tumours with genetic alterations.
    Metz AJ; Bourke MJ; Moss A; Dower A; Zarzour P; Hawkins NJ; Ward RL; Hesson LB
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):319-26. PubMed ID: 23354161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability.
    Kemp Z; Rowan A; Chambers W; Wortham N; Halford S; Sieber O; Mortensen N; von Herbay A; Gunther T; Ilyas M; Tomlinson I
    Cancer Res; 2005 Dec; 65(24):11361-6. PubMed ID: 16357143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracing origin of serrated adenomas with BRAF and KRAS mutations.
    Lee EJ; Choi C; Park CK; Maeng L; Lee J; Lee A; Kim KM
    Virchows Arch; 2005 Sep; 447(3):597-602. PubMed ID: 15991007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
    Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
    Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
    Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
    Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal molecular characterization of endoscopic specimens from colorectal lesions.
    Minarikova P; Benesova L; Halkova T; Belsanova B; Suchanek S; Cyrany J; Tuckova I; Bures J; Zavoral M; Minarik M
    World J Gastroenterol; 2016 May; 22(20):4936-45. PubMed ID: 27239120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.